Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.
But there were some investors who did something on that date who probably recall it with a smile. Anyone who bought shares of Exelixis (NASDAQ: EXEL) at the beginning of 2015 and held on to the stock are now sitting on a return of 1,560%. A $10,000 investment in the biotech less than three years ago would now be worth $166,000.
Exelixis has been one of the hottest biotech stocks in recent years. But can buying this stock still make you rich? It just might.
Source: Fool.com
Pfizer Inc. Stock
€26.47
0.250%
Our community is currently high on Pfizer Inc. with 27 Buy predictions and 5 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 51.11% compared to the current price of 26.47 € for Pfizer Inc..
